Findings reported for patients seeking treatment for opioid use disorder from 2016 to 2020.
Pain Management
News and Features
Extended-release buprenorphine not cost-effective when transmucosal buprenorphine is available for treatment of OUD.
Findings seen in real-world patients with a range of chronic health conditions.
NSAID use positively linked to VTE, with extra VTE events in those with concomitant high-, medium-risk contraception use.
Regardless of prognosis, panel deemed it appropriate to continue opioids, increase monitoring, and avoid opioid tapering.
Cadmium and lead levels significantly higher among exclusive marijuana users.
The ADA guideline aligns with FDA recommendations advising against codeine and tramadol use in pediatric patients.
The manufacturer’s suggested retail price is $44.99 per carton.
Duexis was supplied as a tablet containing 800mg of ibuprofen and 26.6mg of famotidine.
Small proportion of people with sustained or increasing use were older, had more comorbidities, and used other analgesic drugs.
Enhanced policies, as well as technological solutions that can reduce opportunity for error, should be explored and adopted.
Daxxify is supplied as a lyophilized powder for reconstitution in single-dose 50 Unit and 100 Unit vials.
Oral postpartum depression treatment approved; generic naloxone nasal spray now available; weight management drug shows promise in reducing major cardiovascular events; CDC recommends routine use of RSV vaccine; social anxiety disorder spray shows potential.
Fentanyl is responsible for about 70,000 deaths each year in the US.
The product is a therapeutically equivalent version of Narcan® nasal spray.
Reduction seen in severity of pain and improvement in sleep quality for patients after open-heart surgery.
Study shows reduction in acute pain for high- but not low-dose VX-548.
The rule becomes effective August 28, 2023.
Findings seen for women treated for ovarian cancer, with bigger improvement for those with symptoms at baseline.
Reduced odds seen for receiving gabapentin prescription in adults receiving chiropractic spinal manipulative therapy.